These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 25224898

  • 1. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M.
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [Abstract] [Full Text] [Related]

  • 2. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M, Twisk FN, Johnson C.
    Psychiatry Res; 2012 Dec 30; 200(2-3):754-60. PubMed ID: 22521895
    [Abstract] [Full Text] [Related]

  • 3. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.
    J Affect Disord; 2013 Sep 05; 150(2):223-30. PubMed ID: 23664637
    [Abstract] [Full Text] [Related]

  • 4. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G, Maes M.
    Med Hypotheses; 2012 Nov 05; 79(5):607-13. PubMed ID: 22951418
    [Abstract] [Full Text] [Related]

  • 5. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M, Twisk FN.
    Neuro Endocrinol Lett; 2009 Nov 05; 30(6):677-93. PubMed ID: 20038921
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M, Bosmans E, Kubera M.
    Neuro Endocrinol Lett; 2015 Nov 05; 36(5):439-46. PubMed ID: 26707044
    [Abstract] [Full Text] [Related]

  • 7. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
    Maes M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):784-94. PubMed ID: 20609377
    [Abstract] [Full Text] [Related]

  • 8. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M, Twisk FN, Kubera M, Ringel K.
    J Affect Disord; 2012 Feb 29; 136(3):933-9. PubMed ID: 21975140
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M, Leunis JC, Geffard M, Berk M.
    Neuro Endocrinol Lett; 2014 Feb 29; 35(6):445-53. PubMed ID: 25433843
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M, Twisk FN, Ringel K.
    Psychother Psychosom; 2012 Feb 29; 81(5):286-95. PubMed ID: 22832503
    [Abstract] [Full Text] [Related]

  • 11. Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions.
    Morris G, Maes M.
    Neuro Endocrinol Lett; 2013 Feb 29; 34(3):185-99. PubMed ID: 23685416
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M, Leunis JC.
    Neuro Endocrinol Lett; 2014 Feb 29; 35(7):577-85. PubMed ID: 25617880
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G, Anderson G, Maes M.
    Mol Neurobiol; 2017 Nov 29; 54(9):6806-6819. PubMed ID: 27766535
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G, Maes M.
    Metab Brain Dis; 2014 Mar 29; 29(1):19-36. PubMed ID: 24557875
    [Abstract] [Full Text] [Related]

  • 15. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
    Maes M.
    Neuro Endocrinol Lett; 2015 Mar 29; 36(4):320-9. PubMed ID: 26454487
    [Abstract] [Full Text] [Related]

  • 16. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2009 Mar 29; 30(4):470-6. PubMed ID: 20010505
    [Abstract] [Full Text] [Related]

  • 17. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J, Van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Frémont M, Paul L.
    J Intern Med; 2010 Apr 29; 267(4):418-35. PubMed ID: 20433584
    [Abstract] [Full Text] [Related]

  • 18. Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.
    Maes M, Twisk FN.
    BMC Med; 2010 Jun 15; 8():35. PubMed ID: 20550693
    [Abstract] [Full Text] [Related]

  • 19. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
    Maes M, Twisk FN, Kubera M, Ringel K, Leunis JC, Geffard M.
    J Affect Disord; 2012 Feb 15; 136(3):909-17. PubMed ID: 21967891
    [Abstract] [Full Text] [Related]

  • 20. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.
    Morris G, Maes M.
    Metab Brain Dis; 2013 Dec 15; 28(4):523-40. PubMed ID: 22718491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.